Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion
Year: 2020
Type: article
Source: Mucosal Immunology
Institutions: Trudeau Institute, The University of Texas at San Antonio Health Science Center, United States Army Institute of Surgical Research, Brooke Army Medical Center, Regeneron (United States), Centre National de la Recherche Scientifique, Inserm, Aix-Marseille Université, Innate Pharma (France), Centre d’Immunologie de Marseille-Luminy, Hôpital de la Timone
Language: English
Topic: IL-33, ST2, and ILC Pathways
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
Funders: U.S. Department of Agriculture, Cancer Research Institute, Pfizer, Max and Minnie Tomerlin Voelcker Fund, Memorial Sloan-Kettering Cancer Center, Aix-Marseille Université, Crohn's and Colitis Foundation, William and Ella Owens Medical Research Foundation, Georgia Clinical and Translational Science Alliance, European Commission, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, National Institutes of Health, National Institute of Food and Agriculture, University of Texas Health Science Center at San Antonio, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Center for Research Resources, H2020 European Research Council
Awards: G1130591296, G1143455775, Mays Cancer Center at UT Health SA, G1384289361, G1575549460, Defining the role of lymphotoxin signaling in viral-induced lung immunopathology, G1750132693, G2353072465, G2361851875, G2444532981, High Throughput DNA Sequencer: Illumina HiSeq 3000 Sequencer, G3270182855, Institute for Integration of Medicine & Science: A Partnership to Improve Health, G3867857540, G3874765150, G434337789, Innate lymphoid cells in Campylobacter-induced colitis, G5802087626, Targeting Innate Lymphoid Cells, Precision Immuno-Oncology for advanced Non small cell lung cancer patients with PD-1 ICI Resistance, G6420748904, G6610740791, G6803667113, Institute for Integration of Medicine & Science: A Partnership to Improve Health, G9000150452, G9000324485
OpenAlex ID: W3105571165